CA-43-WF29_0.1uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.1uM, (2R)-1-[2-[hydroxy(phosphonooxy)phosphoryl]oxyacetyl]pyrrolidine-2-carboxylic acid, Cholesterol Biosynthesis Inhibitors targeting MVD (Novartis, 44306159)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/44306159
Similar Terms
Downloads & Tools

Genes

16 genes differentially expressed following the CA-43-WF29_0.1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
FKBP1A FK506 binding protein 1A, 12kDa 2.47851
GPX4 glutathione peroxidase 4 1.76786
ANAPC11 anaphase promoting complex subunit 11 1.48693
RPL37 ribosomal protein L37 1.17064
RPL27A ribosomal protein L27a 0.675616
THOC6 THO complex 6 0.654261
LSM7 LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae) 0.427305
MRPL41 mitochondrial ribosomal protein L41 0.337994
VIM vimentin 0.286284
ZNF90 zinc finger protein 90 0.271723
LGALS1 lectin, galactoside-binding, soluble, 1 0.260483
TBCB tubulin folding cofactor B 0.248993
APRT adenine phosphoribosyltransferase 0.229202
LGALS3BP lectin, galactoside-binding, soluble, 3 binding protein 0.225281
ANXA2 annexin A2 0.220205
TIMM8B translocase of inner mitochondrial membrane 8 homolog B (yeast) 0.205403